AllianceBernstein’s Crinetics Pharmaceuticals CRNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.68M | Sell |
93,020
-17,654
| -16% | -$508K | ﹤0.01% | 1787 |
|
|
2025
Q1 | $3.71M | Buy |
110,674
+8,954
| +9% | +$300K | ﹤0.01% | 1576 |
|
|
2024
Q4 | $5.2M | Buy |
101,720
+9,190
| +10% | +$470K | ﹤0.01% | 1471 |
|
|
2024
Q3 | $4.73M | Hold |
92,530
| – | – | ﹤0.01% | 1538 |
|
|
2024
Q2 | $4.14M | Buy |
92,530
+25,260
| +38% | +$1.13M | ﹤0.01% | 1565 |
|
|
2024
Q1 | $3.15M | Hold |
67,270
| – | – | ﹤0.01% | 1669 |
|
|
2023
Q4 | $2.39M | Buy |
67,270
+6,130
| +10% | +$218K | ﹤0.01% | 1840 |
|
|
2023
Q3 | $1.82M | Buy |
61,140
+9,940
| +19% | +$296K | ﹤0.01% | 1921 |
|
|
2023
Q2 | $923K | Hold |
51,200
| – | – | ﹤0.01% | 2322 |
|
|
2023
Q1 | $822K | Hold |
51,200
| – | – | ﹤0.01% | 2321 |
|
|
2022
Q4 | $937K | Hold |
51,200
| – | – | ﹤0.01% | 2319 |
|
|
2022
Q3 | $1.01M | Hold |
51,200
| – | – | ﹤0.01% | 2282 |
|
|
2022
Q2 | $955K | Buy |
51,200
+21,600
| +73% | +$403K | ﹤0.01% | 2367 |
|
|
2022
Q1 | $650K | Buy |
29,600
+100
| +0.3% | +$2.2K | ﹤0.01% | 2557 |
|
|
2021
Q4 | $838K | Hold |
29,500
| – | – | ﹤0.01% | 2526 |
|
|
2021
Q3 | $621K | Hold |
29,500
| – | – | ﹤0.01% | 2664 |
|
|
2021
Q2 | $556K | Buy |
29,500
+2,700
| +10% | +$50.9K | ﹤0.01% | 2762 |
|
|
2021
Q1 | $410K | Sell |
26,800
-1,100
| -4% | -$16.8K | ﹤0.01% | 2745 |
|
|
2020
Q4 | $394K | Buy |
27,900
+2,000
| +8% | +$28.2K | ﹤0.01% | 2697 |
|
|
2020
Q3 | $406K | Hold |
25,900
| – | – | ﹤0.01% | 2636 |
|
|
2020
Q2 | $454K | Buy |
25,900
+11,100
| +75% | +$195K | ﹤0.01% | 2665 |
|
|
2020
Q1 | $218K | Buy |
14,800
+3,000
| +25% | +$44.2K | ﹤0.01% | 2752 |
|
|
2019
Q4 | $296K | Buy |
11,800
+600
| +5% | +$15.1K | ﹤0.01% | 2772 |
|
|
2019
Q3 | $168K | Buy |
11,200
+2,200
| +24% | +$33K | ﹤0.01% | 2969 |
|
|
2019
Q2 | $225K | Buy |
+9,000
| New | +$225K | ﹤0.01% | 2920 |
|